cellular therapy Phoenix: What it means for your joint

What can you do for the soreness today?

Ease the movement that caused the latest flare. Complete rest can make a joint stiff, so keep moving within comfort. Shorten a walk, make fewer trips upstairs, or reach below shoulder height. A cane or a brace can reduce the strain during movement. Ask your own doctor about pain medicine and the other drugs you take.

A useful home step makes an ordinary task easier afterward.

Check the joint later that day and again after sleeping. Write down the task, its length, and what happened later. The notes may show that hills bother a knee. They may show that reaching high bothers a shoulder. This gives your own doctor a clear example to examine.

Watch for a change that isn't like the usual ache. Heat or fast swelling calls for prompt care, especially with fever. Trouble putting weight on the joint also matters. Get quick help for weakness or numbness that is new. A scheduled clinic visit mustn't delay care for these signs.

An exam is useful when the ache disturbs sleep or limits daily tasks. Bring an older X-ray report when one is available. Tell the examiner what has been tried and what still hurts. There's no need to guess the cause before the visit. Describe what the joint does and when it does it.

The short answer is this: calm the flare, keep notes, and seek help for a sharp change.

Sources

1. A meta-analysis of 14 placebo cohorts across 13 Level I trials in 1,076 knee osteoarthritis patients found that intra-articular saline - the placebo - produced pain and function improvements exceeding the minimal clinically important difference at 3 and 6 months.

   Saltzman BM, et al. — The Therapeutic Effect of Intra-articular Normal Saline Injections for Knee Osteoarthritis: A Meta-analysis of Evidence Level 1 Studies. Am J Sports Med, 2017. DOI: 10.1177/0363546516680607.

2. A 2025 meta-analysis of 73 double-blind placebo-controlled injection trials in 5,895 knee osteoarthritis patients found placebo responder rates above 50 percent at 1, 3 and 6 months, declining by 12 months - which is why any uncontrolled 'our patients improved' claim from a clinic is uninterpretable.

   Previtali D, et al. — Placebo response to intra-articular injections in knee osteoarthritis: magnitude, evolution over time, and influencing factors. A systematic review and meta-analysis with meta-regression. EFORT Open Rev, 2025. DOI: 10.1530/EOR-2025-0022.

3. In a 480-patient, four-arm, multicenter randomized phase 2/3 trial, none of three orthobiologic cell injections - autologous bone marrow aspirate concentrate, autologous adipose stromal vascular fraction, or allogeneic umbilical cord tissue-derived mesenchymal stromal cells - was superior to any other, or to a corticosteroid injection control, on pain at 12 months.

   Mautner K, et al. — Cell-based versus corticosteroid injections for knee pain in osteoarthritis: a randomized phase 3 trial. Nat Med, 2023. DOI: 10.1038/s41591-023-02632-w.

4. FDA states in its consumer alert that the only FDA-approved stem cell products in the United States are blood-forming stem cells derived from umbilical cord blood, approved for disorders of the blood-forming system, and that NONE of these products - stem cells, stromal vascular fraction, umbilical cord blood, Wharton's jelly or amniotic fluid - has been approved for the treatment of any orthopedic condition, including osteoarthritis, tendonitis, disc disease, tennis elbow, back pain, hip pain, knee pain, neck pain or shoulder pain.

   US Food and Drug Administration, Center for Biologics Evaluation and Research — Consumer Alert on Regenerative Medicine Products Including Stem Cells and Exosomes. , 2020.